Researchers Call for Continued Multidisciplinary Care Through Adulthood in Prader-Willi Syndrome
December 4th 2021Multidisciplinary care that includes growth hormone treatment should not cease once patients with Prader-Willi syndrome reach adulthood, according to authors of a study on care outcomes.
Read More
PCOS May Predispose Women to Higher Risk of Psychosis, Study Suggests
December 1st 2021This new study from Finland highlights both the potential for severe psychiatric disturbances among women with polycystic ovary syndrome (PCOS) and lack of extensive knowledge of the toll of psychoses among this group.
Read More
Dietary Interventions Improve Fertility Outcomes Among Women With PCOS
November 28th 2021This new review from China investigated the relationship between diet and fertility among women with polycystic ovary syndrome (PCOS) and provides clinical and evidence-based nutrition recommendations to help manage their reproductive health.
Read More
Children With GHD Experience Low Self-Esteem, Impaired Psychosocial Functioning, Study Shows
November 19th 2021Early identification of psychosocial problems and psychotherapeutic care are critical in mitigating issues of low self-esteem and psychosocial maladjustment in children with growth hormone deficiency (GHD).
Read More
Neck Circumference May Indicate Metabolic Risk in Women With PCOS
November 15th 2021Neck circumference may serve as a suitable alternative to waist circumference when gauging cardiometabolic risks, outside of body mass index and waist circumference, among women with polycystic ovary syndrome (PCOS).
Read More
Growth Hormone Therapy Risk, Safety in Pediatric Cancer Survivors Profiled
November 11th 2021Because treatment with growth hormone (GH), often necessitated by GH deficiency from childhood cancer, has been linked to tumorigenesis, concerns remain around its use among childhood cancer survivors.
Read More
Validated Measure Assesses the Impact of Treatment for Growth Hormone Deficiency in Children
November 6th 2021A validation of the observer-reported outcome of the Growth Hormone Deficiency-Child Impact Measure found it valid and reliable to understand the impact of treatment with growth hormone therapy.
Read More
QOL Similar Among Infertile Obese Women With, Without PCOS
November 4th 2021Investigators compared physical and mental health outcomes among infertile women with and without polycystic ovary syndrome (PCOS), who were considered obese, by looking at their dietary intake, eating behavior, physical activity levels, and quality of life (QOL).
Read More
Reducing Obesity, Insulin Resistance May Improve PCOS-Related Outcomes
October 28th 2021Polycystic ovary syndrome (PCOS) is one of the most common reproductive endocrine and metabolic diseases in women of childbearing age, but data that compare outcomes between obese and nonobese patients are scarce—something this study sought to remedy.
Read More
Growth Hormone Treatment May Improve Sleep Efficiency in Prader-Willi Syndrome
October 16th 2021With sleep apnea and abnormal sleep patterns typifying Prader-Willi syndrome, researchers from Sweden and Denmark theorized that treatment with growth hormone may improve both for individuals affected by the rare neurodevelopmental disease.
Read More
Women With PCOS May Reduce T2D Risk With Contraceptive Pill
October 14th 2021University of Birmingham researchers point to potential benefits via reduced unbound active androgens, low levels of which increase the body’s response to insulin and decrease the likelihood of hirsutism in women with polycystic ovary syndrome (PCOS) at risk of developing type 2 diabetes (T2D).
Read More
PCOS Estimated to Cost $8 Billion in Immediate, Long-term Health Issues
September 21st 2021An updated report shows that the long-term cost of treating the health effects of polycystic ovary syndrome (PCOS)—$4.3 billion—is even higher than $3.7 billion it takes to diagnose and treat immediate issues that present for women who are of reproductive age.
Read More
Metformin Linked to Lower COVID-19 Mortality Rates Among Women With T2D, Obesity
December 8th 2020Among women hospitalized with coronavirus disease 2019 (COVID-19), use of metformin—a type 2 diabetes (T2D) drug used to manage blood sugar levels—was associated with a 21.5% lower risk of death.
Read More
Areas to Watch in Specialty Drug Pipeline Include Cancer, Orphan Drugs
October 23rd 2020In her presentation, Aimee Tharaldson, PhD, senior clinical pharmacist of emerging therapeutics at Express Scripts, discussed the upcoming pipeline of specialty drug approvals and their potential impact on the market.
Read More
Succeeding in Value-Based Payment Requires Engaging Pharmacists From Health Plans and Systems
October 21st 2020Pharmacists have an important role to play in the success of value-based payment models, according to panelists who discussed their health plan’s value initiatives at the Academy of Managed Care Pharmacy Nexus 2020 meeting.
Read More